NIRVANA-1: maintenance therapy with niraparib versus niraparib-bevacizumab in patients with advanced ovarian cancer

Sghaier, S; Corbaux, P; Ray-Coquard, I; Lim, MC; Hasegawa, K; Van Nieuwenhuysen, E; Gonzalez, A; Raspagliesi, F; Freyer, G

Freyer, G (通讯作者),HCL Canc Inst, Dept Med Oncol, Lyon, France.;Freyer, G (通讯作者),Lyon 1 Univ, GINECO, Lyon, France.;Freyer, G (通讯作者),Univ Hosp St Etienne, Dept Med Oncol, GINECO, St Etienne, France.

FUTURE ONCOLOGY, 2023; 19 (25): 1715

Abstract

Following the results of the PRIMA and PAOLA-1 trials, the most effective maintenance strategy for International Federation of Gynecology and Obstetri......

Full Text Link